CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d

Hsiao-Chi Tsai; Hong-Lin Su; Chun-Yin Huang; Yi-Chin Fong; Chin-Jung Hsu; Chih-Hsin Tang

doi:10.18632/oncotarget.1998

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

This article has been corrected. Correction in: Oncotarget. 2020; 11:492-492.

CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d

Hsiao-Chi Tsai _, Hong-Lin Su, Chun-Yin Huang, Yi-Chin Fong, Chin-Jung Hsu and Chih-Hsin Tang

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2014; 5:3800-3812. https://doi.org/10.18632/oncotarget.1998

Metrics: PDF 3213 views | HTML 3343 views | ?

Abstract

Hsiao-Chi Tsai1, Hong-Lin Su1, Chun-Yin Huang2,3, Yi-Chin Fong4,5, Chin-Jung Hsu4,5 and Chih-Hsin Tang6,7,8

1 Department of Life Sciences, National Chung Hsing University, Taichung, Taiwan

2 Department of Orthopaedic Surgery, China Medical University Beigang Hospital, Yun-Lin County, Taiwan

3 Graduate Institute of Clinical Medical Science, China Medical University, Taichung, Taiwan

4 School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan

5 Department of Orthopedic Surgery, China Medical University Hospital, Taichung, Taiwan

6 Graduate Institute of Basic Medical Science, China Medical University, Taichung, Taiwan

7 Department of Pharmacology, School of Medicine, China Medical University, Taichung, Taiwan

8 Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan

Correspondence:

Chih-Hsin, Tang , email:

Keywords: Osteosarcoma; MicroRNA; MMP; CTGF; Metastasis

Received: April 13, 2014 Accepted: May 19, 2014 Published: May 21, 2014

Abstract

Osteosarcoma, the most common primary malignant bone tumor, shows potent capacity for local invasion and distant metastasis. Connective tissue growth factor (CTGF/CCN2), a secreted protein, binds to integrins, modulates invasive behavior of certain human cancer cells. Effect of CTGF in metastasis of human osteosarcoma is unknown. We found overexpression of CTGF increasing matrix metalloproteinases (MMPs)-2 and MMP-3 expression as well as promoting cell migration. MicroRNA (miRNA) analysis of CTGF-overexpressed osteosarcoma versus control cells probed mechanisms of CTGF-mediated promotion of migration. Among miRNAs regulated by CTGF, miR-519d was most downregulated after CTGF treatment. Co-transfection with miR-519d mimic reversed CTGF-mediated MMPs expression and cell migration. Also, MEK and ERK inhibitors or mutants reduced CTGF-increased cell migration and miR-519d suppression. By contrast, knockdown of CTGF diminished lung metastasis in vivo. Clinical samples indicate CTGF expression as linked with clinical stage and tumor metastasis. Taken together, data show CTGF elevating MMPs expression and subsequently promoting tumor metastasis in human osteosarcoma, down-regulating miR-519d via MEK and ERK pathways, making CTGF a new molecular therapeutic target in osteosarcoma metastasis.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1998

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

CTGF increases matrix metalloproteinases expression and subsequently promotes tumor metastasis in human osteosarcoma through down-regulating miR-519d

Abstract